These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31487975)

  • 21. Percutaneous Tibial Nerve Stimulation in the Office Setting: Real-world Experience of Over 100 Patients.
    Sirls ER; Killinger KA; Boura JA; Peters KM
    Urology; 2018 Mar; 113():34-39. PubMed ID: 29196071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndrome.
    Rostaminia G; Chang C; Pincus JB; Sand PK; Goldberg RP
    Int Urogynecol J; 2019 Oct; 30(10):1735-1745. PubMed ID: 30498931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with overactive bladder symptom improvement after 1 year of monthly percutaneous tibial nerve stimulation therapy.
    Pincus J; Rostaminia G; Chang C; Gafni-Kane A; Goldberg RP
    Neurourol Urodyn; 2019 Aug; 38(6):1676-1684. PubMed ID: 31107570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary?
    van der Pal F; van Balken MR; Heesakkers JP; Debruyne FM; Bemelmans BL
    BJU Int; 2006 Mar; 97(3):547-50. PubMed ID: 16469023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial.
    Ghijselings L; Renson C; Van de Walle J; Everaert K; Spinoit AF
    Trials; 2021 Apr; 22(1):247. PubMed ID: 33810804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children.
    Barroso U; Viterbo W; Bittencourt J; Farias T; Lordêlo P
    J Urol; 2013 Aug; 190(2):673-7. PubMed ID: 23422257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder.
    Tudor KI; Seth JH; Liechti MD; Ochulor J; Gonzales G; Haslam C; Fox Z; Pakzad M; Panicker JN
    Clin Auton Res; 2020 Feb; 30(1):61-67. PubMed ID: 30074101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study.
    Peters KM; Carrico DJ; MacDiarmid SA; Wooldridge LS; Khan AU; McCoy CE; Franco N; Bennett JB
    Neurourol Urodyn; 2013 Jan; 32(1):24-9. PubMed ID: 22674493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial.
    Manríquez V; Guzmán R; Naser M; Aguilera A; Narvaez S; Castro A; Swift S; Digesu GA
    Eur J Obstet Gynecol Reprod Biol; 2016 Jan; 196():6-10. PubMed ID: 26645117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous Tibial Nerve Stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review.
    Gaziev G; Topazio L; Iacovelli V; Asimakopoulos A; Di Santo A; De Nunzio C; Finazzi-Agrò E
    BMC Urol; 2013 Nov; 13():61. PubMed ID: 24274173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an implant technique and early experience using a novel implantable pulse generator with a quadripolar electrode array at the tibial nerve for refractory overactive bladder.
    Sirls LT; Schonhoff A; Waldvogel A; Peters KM
    Neurourol Urodyn; 2023 Feb; 42(2):427-435. PubMed ID: 36573835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solifenacin succinate versus percutaneous tibial nerve stimulation in women with overactive bladder syndrome: results of a randomized controlled crossover study.
    Vecchioli-Scaldazza C; Morosetti C; Berouz A; Giannubilo W; Ferrara V
    Gynecol Obstet Invest; 2013; 75(4):230-4. PubMed ID: 23548260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of posterior tibial nerve stimulation for the treatment of overactive bladder in women: a systematic review.
    Levin PJ; Wu JM; Kawasaki A; Weidner AC; Amundsen CL
    Int Urogynecol J; 2012 Nov; 23(11):1591-7. PubMed ID: 22411208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of idiopathic overactive bladder in women: Transcutaneous tibial nerve stimulation alone versus combined with pelvic floor muscle training].
    Baati R; Balhi S; Saadi A; Kraiem R; Kennou B; Ayed H; Chebil M
    Prog Urol; 2020 Dec; 30(17):1126-1133. PubMed ID: 32682849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis.
    Burton C; Sajja A; Latthe PM
    Neurourol Urodyn; 2012 Nov; 31(8):1206-16. PubMed ID: 22581511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: Randomized control trial.
    Ramírez-García I; Blanco-Ratto L; Kauffmann S; Carralero-Martínez A; Sánchez E
    Neurourol Urodyn; 2019 Jan; 38(1):261-268. PubMed ID: 30311692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous tibial nerve stimulation versus tolterodine for overactive bladder in women: a randomised controlled trial.
    Preyer O; Umek W; Laml T; Bjelic-Radisic V; Gabriel B; Mittlboeck M; Hanzal E
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():51-6. PubMed ID: 26073262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How I Do It: Transcutaneous tibial nerve stimulation TENSI+ system.
    Cornu JN; Hashim H; Van Der Aa F; De Nunzio C; Perez VG; Ferreira R; Elterman DS
    Can J Urol; 2023 Dec; 30(6):11756-11761. PubMed ID: 38104335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis/painful bladder syndrome: A systematic review and meta-analysis.
    Ghavidel-Sardsahra A; Ghojazadeh M; Rahnama'I MS; Naseri A; Yazdandoost S; Khezerloo T; Seyedi-Sahebari S; Hosseinifard H; Vahed N; Mostafaei H; Salehi-Pourmehr H; Hajebrahimi S
    Neurourol Urodyn; 2022 Feb; 41(2):539-551. PubMed ID: 35032328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study.
    Peters KM; Carrico DJ; Wooldridge LS; Miller CJ; MacDiarmid SA
    J Urol; 2013 Jun; 189(6):2194-201. PubMed ID: 23219541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.